The Ameliorative Roles of Vitamin C and Vitamin D in Sars-Cov-2 (Covid-19) and Respiratory Diseases: A Review
Loading...
Date
Journal Title
Journal ISSN
Volume Title
Publisher
Department of Biochemistry, Nasarawa State University Keffi
DOI
Abstract
Vitamin C and D can decrease the risks associated with viral infections by regulating the body’s
immune system and response against viral activities and decrease the risks and virulence of
severe viral respiratory tract infections. Research and experience have shown that Vitamin C is a
possible therapy for SARS-CoV-2 because vitamin C has a promising role in maintaining proper
body functions and also helps in removing damaged reactive oxygen species (ROS) and protect
cells from oxidative damage. Vitamin C is needed in an adequate amount for proper immune
function and stability which is a panacea for combating the scourge of infectious agents such as
SARS-CoV-2 (Covid-19). Vitamin D has also been shown to ameliorate and cushion the risk of
respiratory tract infections (RTIs) via several metabolic mechanisms and pathways: adequate
concentrations of vitamin D in cells can decrease the amount and release of pro-inflammatory
cytokines which are predominantly released from innate immune cells. In the base membrane,
vitamin D helps to preserve tight junctions. Adequate plasma levels of vitamin D can eliminate
protein-enveloped viruses with cathelicidin (a polypeptide which is mainly expresses in
neutrophils macrophages, epithelial cells) activation. These processes can reduce the risk of a
cytokine storm which often results to severe pneumonia. Clinical trials prove that elevated
amount of 1, 25(OH) vitamin D derivative will potentially decrease the risk of viral pneumonia,
dengue fever, hepatitis B, C and herpes infections. Thus, multivitamins C, D could play a pivotal
role as curative agents against influenza and SARS-CoV-2 infections
Description
Citation
1. Nicholson K, Baker D, Farquhar A, Hurd D, Kent J, Smith S. Acute upper respiratory tract viral illness and influenza immunization in homes for the elderly. Epidemiol Infect. 1990; 105(3): 609–618. 2. Grant WB, Lahore H, McDonnell SL, Baggerly CA, French CB, Aliano JL. Vitamin D Supplementation Could Prevent and Treat Influenza, Coronavirus, and Pneumonia Infections. Nutrients 2020. 12(1):988. 3. Sacco R, Nonnecke B, Palmer M, Waters WR, Lippolis J, Reinhardt TA. Differential expression of cytokines in response to respiratory syncytial virus infection of calves with high or low circulating 25-hydroxyvitamin D 3. PLoS One 2012;7(3):e33074. 4. Carvajal JJ, Avellaneda AM, Salazar-ardiles C, Maya JE. Host Components Contributing to Respiratory Syncytial Virus Pathogenesis. Front Immunol. 2019; 10(2152):1–19. 5. Thornton C, Salazar JC, Georgountzou A. Postnatal innate immune Development : From Birth to Adulthood. Front Immunol. 2017;8(1):1–16. 6. Lee BL, Moon JE, Shu JH, Yuan L, Newman ZR, Schekman R, UNC93B1 mediates differential trafficking of endosomal TLRs. eLife 2013; 2:e00291. 7. Cheng Y, Liu Y, Shi S, Niu Q, Zhu W, Wang Z. Functional Characterization of Duck STING in IFN-β Induction and Anti-H9N2 Avian Influenza Viruses Infections. Front Immunol. 2019;10:1–10. 8. Ikemoto Y, Kuroda K, Nakagawa K, Ochiai A, Ozaki R, Murakami K. Vitamin D regulates maternal T-helper cytokine production in infertile women. Nutrients. 2018; 10(7):1–10. 9. Bohmwald K, Gálvez NMS, Canedo-Marroquín G, Pizarro- Ortega MS, Andrade-Parra C, Gómez-Santander F. Contribution of cytokines to tissue damage during human respiratory syncytial virus infection. Front Immunol. 2019; 10:1–16.
